Showing all 7 results
Darifenacin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix Prolonged-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute physical stability of the controlled-release polymer.
Active Ingredient Strength Primary Clinical Function Darifenacin Hydrobromide USP/Ph.Eur.
(Equivalent to Darifenacin base)7.5 mg (PR) The Standard Titration & Geriatric Anchor: The definitive, highly efficacious starting and maintenance dose utilized for the vast majority of patients to control OAB symptoms with minimal side effects. Darifenacin Hydrobromide USP/Ph.Eur. 15 mg (PR) The Severe Refractory Macrodose: High-efficacy therapeutic payload utilized strictly for patients who require greater symptom relief and have demonstrated high tolerability to the 7.5 mg dose. Excipients Hypromellose (HPMC) / Dibasic Calcium Phosphate / Magnesium Stearate / Polyethylene Glycol / Titanium Dioxide / Premium Polymeric Film Hydrophilic PR Matrix / Diluent / Lubricant / Plasticizer / Opaque Film (Engineered specifically utilizing high-viscosity Hypromellose. Upon contact with gastrointestinal fluids, the tablet hydrates to form a thick, gelatinous outer layer that strictly controls the diffusion of the highly soluble hydrobromide salt over a 24-hour period) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic urological dispensing regimens).
Desmopressin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Extreme Microdose Peptide Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical stability of the fragile acetate salt.
Active Ingredient Strength Primary Clinical Function Desmopressin Acetate USP/Ph.Eur.
(Equivalent to Desmopressin base)0.1 mg The Titration & Pediatric Anchor: The definitive starting dose utilized for primary nocturnal enuresis in children or baseline control of Central Diabetes Insipidus. Desmopressin Acetate USP/Ph.Eur. 0.2 mg The Maintenance Macrodose: High-efficacy therapeutic payload utilized for severe, refractory polyuria and nocturia in adults. Excipients Lactose Monohydrate / Potato Starch / Povidone K-30 / Magnesium Stearate Diluent / Disintegrant / Binder / Lubricant (Engineered specifically utilizing Strict Geometric Dilution to ensure the microscopic peptide payload is flawlessly uniform, manufactured under stringent low-moisture conditions to prevent hydrolytic degradation of the fragile peptide bonds) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30/100 or 10×10 Alu-Alu Blisters (Optimized specifically for strict chronic endocrine dispensing regimens).
Nitrofurantoin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Dual-Release Capsule or Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the nitrofuran compounds.
Active Ingredient Strength Primary Clinical Function Nitrofurantoin (Macrocrystals) USP/Ph.Eur. 50 mg Prophylactic / Pediatric Standard: Base therapeutic unit for long-term prevention of recurrent UTIs and pediatric dosing. Nitrofurantoin (Macrocrystals 25mg + Monohydrate 75mg) USP 100 mg Global Acute UTI Standard: Premium dual-release adult maintenance dose for the rapid eradication of acute uncomplicated cystitis. Excipients Carbomer 934P / Povidone K30 / Sugar Spheres / Talc / Magnesium Stearate / Titanium Dioxide Hydrophilic Polymer Matrix / Binder / Core Substrate / Glidant (Engineered specifically to form a viscous gel upon swallowing, pacing the gastric release perfectly to prevent nausea while ensuring maximum urinary concentration) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict 5-to-7 day acute urology dispensing regimens).
Oxybutynin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE desiccant bottles to ensure the absolute chemical stability of the controlled-release hydrogel network.
Active Ingredient Strength Primary Clinical Function Oxybutynin Chloride USP/Ph.Eur. 5 mg (ER) Initiation Standard: Base once-daily titration unit for the gradual introduction of antimuscarinic therapy. Oxybutynin Chloride USP/Ph.Eur. 10 mg / 15 mg (ER) Global Clinical Standard: Advanced maintenance doses for severe, refractory Overactive Bladder and neurogenic detrusor overactivity. Excipients Hypromellose (HPMC) / Lactose Anhydrous / Macrogol (PEG) / Magnesium Stearate / Titanium Dioxide Hydrophilic Polymer Matrix / Diluent / Plasticizer / Premium Film-Coating (Engineered specifically to form a highly viscous external gel barrier upon swallowing, controlling the exact 24-hour drug diffusion rate) *Pack Sizes: Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for strict, high-compliance 30-day chronic urology dispensing regimens).
Silodosin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Silodosin INN/Ph.Eur. 8 mg Global Clinical Standard: Maximum adult daily dose for the rapid relief of lower urinary tract symptoms (LUTS) associated with BPH. Excipients Mannitol / Pregelatinized Starch / Sodium Stearyl Fumarate / Hypromellose / Titanium Dioxide Diluent / Binder / Lubricant / Film-Coating (Engineered for highly synchronized gastric dissolution and optimal bioavailability) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for high-compliance 30-day urology dispensing regimens).
Solifenacin Succinate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or High-Density Alu-PVC blister strips to ensure the absolute stability of the low-dose API.
Active Ingredient Strength Primary Clinical Function Solifenacin Succinate USP/Ph.Eur. 5 mg Global Standard: Starting and standard maintenance dose for Overactive Bladder; required maximum dose for patients with hepatic/renal impairment. Solifenacin Succinate USP/Ph.Eur. 10 mg High-Dose Therapy: Maximum adult dose for severe, refractory urinary urgency and frequency. Excipients Lactose Monohydrate / Maize Starch / Hypromellose / Magnesium Stearate / Macrogol Diluent / Binder / Premium Film-Coating (Engineered for immediate gastric dissolution and light protection)
